The Endowment Effect: Why You Can't Sell Your Vested Stock

Richard Thaler documented the endowment effect in 1980: people demand more to give up an object than they would pay to acquire the same object. The effect is robust across repeated experimental setups, across cultures, across asset classes, and across price levels. It is also one of the primary reasons that tech employees hold employer stock long past the point where any rational portfolio allocation would sell.

The economic thought experiment is straightforward. You hold 5,000 vested shares of your employer at $140. You are asked: would you buy 5,000 shares at $140 if you had the cash in your checking account and no existing position? Almost every senior IC answers no, that’s too concentrated for my portfolio. The next question: will you sell the 5,000 shares at $140 and put the proceeds into a diversified portfolio? Almost every senior IC answers no, I want to hold for the upside.

The two answers are mutually inconsistent under any coherent utility function. The same position, at the same price, cannot be “too concentrated to buy” and “too good to sell.” The inconsistency is the endowment effect operating in full force.

This article walks through why the effect is so stubborn, how it specifically damages equity-compensation outcomes, and what actually works to overcome it.

The Experimental Evidence

Thaler, Knetsch, and Kahneman ran the canonical experiment with coffee mugs in 1990. Half the participants received a $6 coffee mug. Half did not. Participants who owned a mug on average demanded $7.12 to give it up. Participants who did not own a mug were on average willing to pay $2.87 to acquire one. The ratio of 2.5x between willingness-to-accept and willingness-to-pay is typical of endowment-effect studies.

The effect is not a minor statistical artifact. It has been replicated hundreds of times with mugs, chocolate, lottery tickets, wine, and, in a 2002 study, actual securities. It operates at low stakes and high stakes. It operates when the owner has held the object for minutes or for years.

In equity comp, the endowment effect compounds with other biases:

• Anchoring on the highest recent price. If your stock hit $220 last year and is at $140 now, you value it at “close to $220” in your mental model.
• Loss aversion on selling below the price at which you first saw it vest. A vest at $180, now trading at $140, feels like a $40 loss per share, not a $140 gain over the $0 grant price.
• Identity as an owner. “I am a shareholder” becomes part of the self-narrative, and selling feels like departure from a tribe.

Why It Specifically Damages Tech-Employee Portfolios

A standard portfolio recommendation for a senior IC in the FAANG tier says: do not hold more than 10-15% of net worth in any single stock. This maps to roughly $200,000 to $400,000 of employer stock for a $2M net worth, or $1M to $1.5M for a $10M net worth.

Actual senior IC portfolios, pulled from family-office intakes in 2024-2025, routinely show 40-70% concentration in employer stock even 3-5 years after IPO. A 2023 Vanguard study of plan participants at 50 large public employers found that employees held on average 21% of their 401(k) balance in employer stock. For tech employees at FAANG companies, the concentration is higher once non-401(k) RSU holdings are included; informal surveys suggest 45-55% average concentration.

The endowment effect drives this because every quarterly sell decision feels like a departure from the owned position. The question “should I sell 500 shares this quarter” is reframed as “should I give up 500 shares I own,” which triggers the WTA premium. The employee defers. The next quarter, the same decision recurs. Nothing is sold.

Over four years of vesting at $500,000 per year, an employee who defers selling every quarter accumulates $2M in concentrated stock. If the stock doubles, $4M. If the stock halves, $1M and a 50% loss on employer-specific risk.

The Two Cases Where Endowment Bias Actually Pays Off

The endowment effect is not pathological in every case. Two specific cases where holding is rational:

1. Pre-IPO private company stock. Holding the stock may have QSBS (§1202) benefits that would be lost on a pre-five-year sale. The stock may have significant upside from the next financing round. Holding is consistent with the concentration risk you accepted when you joined.

2. Concentrated equity at a company you genuinely have inside information on. A senior executive with material non-public information cannot trade; the endowment “effect” is a legal constraint, not a bias.

Outside these two cases, holding is typically driven by bias rather than thesis. The employee who says “I think the stock will outperform” when asked to justify holding rarely has a differentiated view beyond “the company is great.” Great companies can trade at fair value. Fair value does not justify concentration.

Mechanisms That Actually Overcome the Effect

Research on debiasing shows that most “just think harder” interventions fail. The endowment effect is largely automatic. What works is structural:

1. Pre-commitment through 10b5-1 plans. A Rule 10b5-1(c)(1) plan locks in a sale schedule before the blackout window. Once established, the plan sells whether you want to or not. The endowment moment does not arise because you do not have a decision to make. Minimum cooling-off period of 90 days before first trade.

2. Exchange funds (§721 swap). Contribute concentrated stock to an exchange fund, receive a diversified portfolio in return, defer gain recognition for 7+ years. The psychological shift: you stop “owning” a specific stock and start “owning” a fund. The endowment attaches to the fund.

3. Staged selling with pre-set triggers. Decide in advance: sell 25% of every vest at vest, sell another 25% at vest + 12 months, sell another 25% at vest + 24 months, sell the final 25% opportunistically. The schedule removes the quarterly decision.

4. Direct indexing offset. Sell employer stock, buy a direct-indexed portfolio that excludes the employer stock’s sector exposure. The personal benchmark is your total portfolio, not your employer stock specifically.

5. Charitable gifting to a DAF. Move concentrated stock to a donor-advised fund. The stock is no longer yours; the DAF is. The endowment effect does not apply to money you have committed to charity.

Each of these mechanisms works by changing the decision frame from “give up something I own” to “operate under a pre-committed rule.”

The Quantitative Cost of the Effect

A senior IC who should be selling 25% of every vest but holds everything is bearing roughly 30-40 percentage points of additional equity-concentration risk over what a diversified portfolio would carry.

Fama-French factor analysis of single-stock volatility suggests that typical tech-company stock has 35-45% annualized volatility versus 18-22% for the S&P 500. Holding 50% of net worth in employer stock adds approximately 12-15 percentage points of portfolio volatility versus the diversified alternative.

In expected-return terms, the employer stock does not compensate for this extra risk. The CAPM expected return for a single tech stock is not 10% higher than the market; it is 1-3% higher at most, with 35-45% volatility. The Sharpe-ratio impact of concentration is negative.

Over a 10-year horizon, the expected cost of holding 50% in employer stock versus diversifying is roughly 1-2% per year in risk-adjusted return. On a $5M portfolio, that’s $50,000-$100,000 per year of expected-utility cost. Cumulative over a decade: $500,000 to $1M of expected value lost to the endowment effect.

Implementation for Someone Who Cannot Sell

If you have read this and still cannot sell, the least-bad workaround is to hedge the position. A protective put or a collar strategy at a strike price 10-15% below current offers downside protection with minimal premium cost.

For a $2M position at $140, a collar (long put at $125, short call at $170) for a 12-month expiry typically costs zero in net premium but caps upside at $170 and protects downside at $125. The hedge does not reduce concentration, but it removes the worst outcomes.

IRC §1259 constructive-sale rules limit fully-offsetting positions. A true collar within the §1259 safe harbor (put and call with meaningful spread) does not trigger constructive sale. An at-the-money put and at-the-money call with identical strikes would trigger §1259 and cause immediate gain recognition.

Collars are a stopgap. They do not solve the underlying bias. But they do protect against the specific scenario the endowment-biased employee is most exposed to: a 60% drawdown on concentrated employer stock.

Frequently Asked

If everyone has the endowment effect, does it just net out in the market? Yes, at the aggregate level. The effect does not change market prices. It changes who holds what. For the individual, the cost is concentration risk and tax inefficiency, not foregone alpha.

Does the effect apply to cash? No. Cash is fungible. The effect requires the owned item to have some distinguishing characteristic.

Does it apply to index fund shares? Weakly. Broad-index holdings feel less “mine” than single-stock holdings. This is one reason diversified portfolios are easier to rebalance than concentrated ones.

Can I talk myself out of the effect? Rarely. The effect operates below conscious reflection. What works is changing the decision structure so that the default outcome is the right outcome, not hoping you will override the bias in real time.

Is the endowment effect the same as sunk-cost fallacy? No. Sunk cost is about past investment making you stay in a position. Endowment is about current ownership making you overvalue what you hold. They can co-occur but are distinct biases.